CoChat

Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance

Open access
Latour, Mélodie, Kwiatek, Lauren, Landry-Voyer, Anne-Marie, Bachand, François · 2025 · Nucleic Acids Research

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; none of the 70 sources its claims cite is checked for support yet.

Abstract

Most eukaryotic genomes are transcribed pervasively, thereby producing an array of long non-coding RNAs (lncRNAs) in addition to protein-coding mRNAs. A large fraction of these lncRNAs is targeted by polyadenylation-dependent decay via the poly(A)-binding protein nuclear 1 (PABPN1) and the RNA exosome. Yet, how PABPN1 contributes to nuclear RNA surveillance by facilitating lncRNA turnover by the RNA exosome remains largely unclear. Here, we show that PABPN1 is important for the nuclear retention of polyadenylated lncRNAs, such that PABPN1 loss of function allows target lncRNAs to evade nuclear decay, leading to cytoplasmic accumulation. Interestingly, we found that another nuclear PABP, ZC3H14, functions antagonistically to PABPN1 and the poly(A)-tail exosome targeting (PAXT) connection in the control of nuclear lncRNA turnover. Collectively, our findings disclose the critical interplay between two conserved nuclear PABPs, PABPN1 and ZC3H14, in RNA surveillance via the control of nuclear RNA export.

Overview

CoChat Summary

TL;DR

PABPN1 and ZC3H14 are conserved nuclear poly(A)-binding proteins that physically associate and act antagonistically in nuclear RNA surveillance: PABPN1 promotes nuclear retention and PAXT/exosome-dependent decay of polyadenylated lncRNAs, while ZC3H14 opposes this and favors their stability/export. This interplay controls a set of noncoding transcripts, exemplified by SNHG19.

Key findings

  • Proximity-dependent biotinylation MS identified 75 ZC3H14-proximal and 138 PABPN1-proximal proteins, with 62 of 75 ZC3H14 interactors (83%) also PABPN1-associated (P < 2.5e-126); the PABPN1–ZC3H14 association was sensitive to RNase I but not RNases A/T1, suggesting dependence on poly(A)-tail integrity.
  • PABPN1 depletion reduced ZC3H14 proximity to PAXT/3′-end-processing/export factors, while ZC3H14 depletion reduced PABPN1 accumulation in nuclear speckles.
  • For SNHG19 lncRNA, PABPN1 knockdown caused a ~10-fold increase, ZC3H14 knockdown caused a ~2-fold decrease, and double PABPN1/ZC3H14 depletion reduced SNHG19 versus PABPN1 single depletion; ZC3H14 bound SNHG19 and promoted its stability, restricting PAXT-dependent decay via RBM26/RBM27 and ZFC3H1 but not ZC3H3.
  • RNA-seq found 1223 upregulated and 1293 downregulated genes (>1.5-fold) in PABPN1-deficient cells, versus 362 upregulated and 379 downregulated in ZC3H14-deficient cells; 39 genes were antagonistically regulated, of which 26 (67%) were lncRNAs, antisense RNAs, or novel noncoding transcripts. PABPN1 loss caused cytoplasmic SNHG19 accumulation, ZC3H14 loss decreased nuclear/cytoplasmic signal, and double depletion increased the nuclear-to-cytoplasmic ratio; NXF1 or UAP56 depletion countered the cytoplasmic accumulation seen with PABPN1 loss.

Methods

  • Cell culture and depletion assays in HeLa, HEK293T, and HEK 293-FT cells using siRNA/shRNA knockdowns and inducible GFP- or BirA-tagged PABPN1/ZC3H14 expression.
  • Proximity-dependent biotinylation coupled to LC-MS/MS (PDB-MS/BioID) analyzed with SAINT (FDR ≤ 0.05, log2 fold-change ≥ 1.0) and DEqMS for differential interactions; total RNA-seq on Illumina HiSeq aligned to GRCh38 and analyzed with edgeR.
  • Validation by RT-qPCR, actinomycin D stability assays, RNA and protein co-immunoprecipitation, immunofluorescence, FISH/RNAscope, cellular fractionation, and western blotting, with t tests or ANOVA for statistical comparisons.

Limitations

  • Stated: siRNA-mediated depletions may have secondary/off-target effects, although the authors designed siRNAs to minimize these; the authors state they have not definitively proven that PABPN1 and ZC3H14 share binding to poly(A) tails of target transcripts; how ZC3H14 impedes PABPN1 function and the specificity of PABPN1-dependent nuclear retention remain to be determined.
  • Evident from the text: most mechanistic work is in cultured HeLa/HEK293T cells rather than in vivo models; ZC3H14 depletion caused relatively few transcriptome changes, and the authors note that ZC3H14 activity as a positive or negative regulator may depend on phosphorylation, which was not directly resolved here.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/nar/gkaf060

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical Abstract
Graphical Abstract CC BY · PubMed Central
Figure 1. ZC3H14 and PABPN1 interact with a common set of RNA-binding proteins. (A and B) Scatterplots showing results from PDB-MS assays using BirA-ZC3H14 (A, n = 5) and BirA-PABPN1 (B, n = 3) plotted by Log Odds Score on the x-axis, which reflects the probability of a true protein–protein interaction; and fold change up the y-axis, reflecting relative enrichment in the streptavidin pull-down. Selected proteins are indicated. (C) Venn diagram of significant interactions partners detected by PDB-MS analysis of ZC3H14 and PABPN1 after running SAINTexpress. (D) GO enrichment analysis (biological process) of 62 overlapping proteins identified by PDB-MS analysis of ZC3H14 and PABPN1. The biological process and the number of proteins associated with each one are indicated. (E) Network of the common ZC3H14- and PABPN1-proximal interactome organized by biological processes found to be significantly enriched. (F) Western blot analysis of total extracts (lanes 1 and 5) and GFP immunoprecipitates (lanes 2–4 and 6–8) prepared from stable HEK293T cells expressing GFP (lanes 1–4) and GFP-PABPN1 (lanes 5–8). Total cell extracts were either treated (lanes 3–4 and 7–8) or not treated (lanes 2 and 6) with the indicated RNases before immunoprecipitation. Anti-GFP, anti-Tubulin, and anti-ZC3H14 were used for Western blotting. The asterisk indicates a non-specific protein that cross-reacts with the ZC3H14 antibody. (G) Agarose gel analysis of total extracts prepared from HEK293T cells expressing GFP (lanes 1–3) and GFP-PABPN1 (lanes 5–7) that were either treated (lanes 1–2 and 5–6) or not treated (lanes 3 and 7) with the indicated RNases to digest cellular RNAs. Cellular ribonucleoprotein (RNP) complexes are indicated on the right.
Figure 1. ZC3H14 and PABPN1 interact with a common set of RNA-binding proteins. (A and B) Scatterplots showing results from PDB-MS assays using BirA-ZC3H14 (A, n = 5) and BirA-PABPN1 (B, n = 3) plotted by Log Odds Score on the x-axis, which reflects the probability of a true protein–protein interaction; and fold change up the y-axis, reflecting relative enrichment in the streptavidin pull-down. Selected proteins are indicated. (C) Venn diagram of significant interactions partners detected by PDB-MS analysis of ZC3H14 and PABPN1 after running SAINTexpress. (D) GO enrichment analysis (biological process) of 62 overlapping proteins identified by PDB-MS analysis of ZC3H14 and PABPN1. The biological process and the number of proteins associated with each one are indicated. (E) Network of the common ZC3H14- and PABPN1-proximal interactome organized by biological processes found to be significantly enriched. (F) Western blot analysis of total extracts (lanes 1 and 5) and GFP immunoprecipitates (lanes 2–4 and 6–8) prepared from stable HEK293T cells expressing GFP (lanes 1–4) and GFP-PABPN1 (lanes 5–8). Total cell extracts were either treated (lanes 3–4 and 7–8) or not treated (lanes 2 and 6) with the indicated RNases before immunoprecipitation. Anti-GFP, anti-Tubulin, and anti-ZC3H14 were used for Western blotting. The asterisk indicates a non-specific protein that cross-reacts with the ZC3H14 antibody. (G) Agarose gel analysis of total extracts prepared from HEK293T cells expressing GFP (lanes 1–3) and GFP-PABPN1 (lanes 5–7) that were either treated (lanes 1–2 and 5–6) or not treated (lanes 3 and 7) with the indicated RNases to digest cellular RNAs. Cellular ribonucleoprotein (RNP) complexes are indicated on the right.CC BY · PubMed Central
Figure 2. Functional connection between PABPN1 and ZC3H14. (A) Volcano plot of statistical significance (false discovery rate) against fold change (in log2) of ZC3H14-proximal proteins in HEK293T cells treated with PABPN1-specific siRNAs relative to cells treated with nontarget control siRNAs (N = 3 biological replicates). The dashed lines represent the thresholds for calling significant differential ZC3H14 association: FDR ≤ 0.05 and absolute log2 fold change ≥ 1.0. Proteins showing significantly decreased and increased ZC3H14-proximal biotinylation in PABPN1-deficient cells are shown in red and blue, respectively. (B) Immunostaining analysis of fixed and permeabilized HeLa cells that were previously transfected with control (a–d) and PABPN1-specific (e–h) siRNAs were stained with antibodies specific for ZC3H14 (a and e) and SC35 (b and f). DNA was stained with DAPI to show the nucleus (c and g). Images a–c, and e–g were merged to form d and h, respectively. Bar, 5 μm. (C) Violin plots with nuclear speckle ZC3H14 fluorescence mean intensity scores for cells transfected with the indicated siRNAs from two independent replicates. The total number of nuclei analyzed are indicated under each plot. Statistical differences were calculated using a unpaired student T-test for pairwise comparison (siControl and siPABPN1). ns, not significant. (D) Volcano plot of statistical significance (false discovery rate) against fold change (in log2) of PABPN1-proximal proteins in HEK293T cells treated with ZC3H14-specific siRNAs relative to cells treated with non-target control siRNAs (N = 3 biological replicates). The dashed lines represent the thresholds for calling significant differential PABPN1 association: FDR ≤ 0.05 and absolute log2 fold change ≥ 1.0. Proteins showing significantly decreased and increased PABPN1-proximal biotinylation in ZC3H14-deficient cells are shown in red and blue, respectively. (E) Immunostaining analysis of fixed and permeabilized HeLa cells that were previously transfected with control (a–d) and ZC3H14-specific (e–h) siRNAs were stained with antibodies specific for PABPN1 (a and e) and SC35 (b and f). DNA was stained with DAPI to show the nucleus (c and g). Images a–c, and e–g were merged to form d and h, respectively. Bar, 5 μm. (F) Violin plots with nuclear speckle PABPN1 fluorescence mean intensity scores for cells transfected with the indicated siRNAs from two independent replicates. The total number of nuclei analyzed are indicated under each plot. Statistical differences were calculated using a unpaired student T-test for pairwise comparison (siControl and siZC3H14). P-value ****, <0.0001.
Figure 2. Functional connection between PABPN1 and ZC3H14. (A) Volcano plot of statistical significance (false discovery rate) against fold change (in log2) of ZC3H14-proximal proteins in HEK293T cells treated with PABPN1-specific siRNAs relative to cells treated with nontarget control siRNAs (N = 3 biological replicates). The dashed lines represent the thresholds for calling significant differential ZC3H14 association: FDR ≤ 0.05 and absolute log2 fold change ≥ 1.0. Proteins showing significantly decreased and increased ZC3H14-proximal biotinylation in PABPN1-deficient cells are shown in red and blue, respectively. (B) Immunostaining analysis of fixed and permeabilized HeLa cells that were previously transfected with control (a–d) and PABPN1-specific (e–h) siRNAs were stained with antibodies specific for ZC3H14 (a and e) and SC35 (b and f). DNA was stained with DAPI to show the nucleus (c and g). Images a–c, and e–g were merged to form d and h, respectively. Bar, 5 μm. (C) Violin plots with nuclear speckle ZC3H14 fluorescence mean intensity scores for cells transfected with the indicated siRNAs from two independent replicates. The total number of nuclei analyzed are indicated under each plot. Statistical differences were calculated using a unpaired student T-test for pairwise comparison (siControl and siPABPN1). ns, not significant. (D) Volcano plot of statistical significance (false discovery rate) against fold change (in log2) of PABPN1-proximal proteins in HEK293T cells treated with ZC3H14-specific siRNAs relative to cells treated with non-target control siRNAs (N = 3 biological replicates). The dashed lines represent the thresholds for calling significant differential PABPN1 association: FDR ≤ 0.05 and absolute log2 fold change ≥ 1.0. Proteins showing significantly decreased and increased PABPN1-proximal biotinylation in ZC3H14-deficient cells are shown in red and blue, respectively. (E) Immunostaining analysis of fixed and permeabilized HeLa cells that were previously transfected with control (a–d) and ZC3H14-specific (e–h) siRNAs were stained with antibodies specific for PABPN1 (a and e) and SC35 (b and f). DNA was stained with DAPI to show the nucleus (c and g). Images a–c, and e–g were merged to form d and h, respectively. Bar, 5 μm. (F) Violin plots with nuclear speckle PABPN1 fluorescence mean intensity scores for cells transfected with the indicated siRNAs from two independent replicates. The total number of nuclei analyzed are indicated under each plot. Statistical differences were calculated using a unpaired student T-test for pairwise comparison (siControl and siZC3H14). P-value ****, <0.0001.CC BY · PubMed Central
Figure 3. PABPN1 and ZC3H14 antagonistically regulate the expression of the SNHG19 lncRNA. (A) Schematic of the SNHG19 lncRNA expression. The blue rectangles represent the SNHG19 non-coding exons, while the red box corresponds to intronic SNORD60. Polyadenylation-dependent RNA degradation of the spliced SNHG19 lncRNA is promoted by PABPN1 and PAXT in the nucleus. (B) Western blot analysis of ZC3H14, PABPN1, and tubulin proteins using total extracts prepared from HeLa cells previously transfected with the indicated siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. (C and D) RT-qPCR analysis of SNHG19 lncRNA from total RNA harvested from HeLa cells that were previously transfected with the indicated siRNAs. Data and error bars represent the means and standard deviations of five independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗) ≤0.001; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test. (E and F) HeLa cells previously transfected with the indicated siRNAs were treated with 5 mg/ml actinomycin D and total RNA was isolated at the indicated time points. The degradation rate of spliced SNHG19 lncRNA was determined by RT-qPCR analysis and normalized to 18S rRNA. Data and error bars represent the mean and standard deviation of three independent experiments. P-values were calculated using Two-way ANOVA tests. (G) Fold mRNA enrichment (IP/input ratio) for the indicated the uS5 mRNA and the SNHG19 lncRNA in GFP-ZC3H14 immunoprecipitates was analyzed by RT-qPCR and normalized to a control housekeeping mRNA (GAPDH). Values were then set to 1.0 for the control GFP purification. Data and error bars represent the means and standard deviations of four independent experiments, respectively. P value (∗∗∗∗) <0.0001 was determined with an unpaired Student t test.
Figure 3. PABPN1 and ZC3H14 antagonistically regulate the expression of the SNHG19 lncRNA. (A) Schematic of the SNHG19 lncRNA expression. The blue rectangles represent the SNHG19 non-coding exons, while the red box corresponds to intronic SNORD60. Polyadenylation-dependent RNA degradation of the spliced SNHG19 lncRNA is promoted by PABPN1 and PAXT in the nucleus. (B) Western blot analysis of ZC3H14, PABPN1, and tubulin proteins using total extracts prepared from HeLa cells previously transfected with the indicated siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. (C and D) RT-qPCR analysis of SNHG19 lncRNA from total RNA harvested from HeLa cells that were previously transfected with the indicated siRNAs. Data and error bars represent the means and standard deviations of five independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗) ≤0.001; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test. (E and F) HeLa cells previously transfected with the indicated siRNAs were treated with 5 mg/ml actinomycin D and total RNA was isolated at the indicated time points. The degradation rate of spliced SNHG19 lncRNA was determined by RT-qPCR analysis and normalized to 18S rRNA. Data and error bars represent the mean and standard deviation of three independent experiments. P-values were calculated using Two-way ANOVA tests. (G) Fold mRNA enrichment (IP/input ratio) for the indicated the uS5 mRNA and the SNHG19 lncRNA in GFP-ZC3H14 immunoprecipitates was analyzed by RT-qPCR and normalized to a control housekeeping mRNA (GAPDH). Values were then set to 1.0 for the control GFP purification. Data and error bars represent the means and standard deviations of four independent experiments, respectively. P value (∗∗∗∗) <0.0001 was determined with an unpaired Student t test.CC BY · PubMed Central
Figure 4. ZC3H14 restricts PAXT-mediated degradation of the SNHG19 lncRNA. (A) Western blot analysis of ZC3H14, RBM26, and tubulin proteins using total extracts prepared from HeLa cells previously transfected with the indicated combination of siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. (B) RT-qPCR analysis of SNHG19 lncRNA from total RNA harvested from HeLa cells that were previously transfected with the indicated combination of siRNAs. Data and error bars represent the means and standard deviations of four independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗) ≤0.001; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test. (C) Western blot analysis of ZC3H14, ZFC3H1, ZC3H3, and tubulin proteins using total extracts prepared from HeLa cells previously transfected with the indicated combination of siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. The asterisk (*) indicates the position of ZC3H3. (D) RT-qPCR analysis of SNHG19 lncRNA from total RNA harvested from HeLa cells that were previously transfected with the indicated combination of siRNAs. Data and error bars represent the means and standard deviations of six independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test.
Figure 4. ZC3H14 restricts PAXT-mediated degradation of the SNHG19 lncRNA. (A) Western blot analysis of ZC3H14, RBM26, and tubulin proteins using total extracts prepared from HeLa cells previously transfected with the indicated combination of siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. (B) RT-qPCR analysis of SNHG19 lncRNA from total RNA harvested from HeLa cells that were previously transfected with the indicated combination of siRNAs. Data and error bars represent the means and standard deviations of four independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗) ≤0.001; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test. (C) Western blot analysis of ZC3H14, ZFC3H1, ZC3H3, and tubulin proteins using total extracts prepared from HeLa cells previously transfected with the indicated combination of siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. The asterisk (*) indicates the position of ZC3H3. (D) RT-qPCR analysis of SNHG19 lncRNA from total RNA harvested from HeLa cells that were previously transfected with the indicated combination of siRNAs. Data and error bars represent the means and standard deviations of six independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test.CC BY · PubMed Central
Figure 5. Antagonistic regulation of ncRNA expression by PABPN1 and ZC3H14. (A–C) Read coverage over the SNHG19 (A), LINC01273 (B), and NALT1 (C) genes from RNA-seq data of HeLa cells previously transfected with the indicated siRNAs. Transcript annotations are from GENCODE V44. (D–E) RT-qPCR analysis of LINC01273 (D) and NALT1 (E) ncRNA genes using total RNA harvested from HeLa cells that were previously transfected with combination of the indicated siRNAs. Data and error bars represent the means and standard deviations of five independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗) ≤0.001; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test.
Figure 5. Antagonistic regulation of ncRNA expression by PABPN1 and ZC3H14. (A–C) Read coverage over the SNHG19 (A), LINC01273 (B), and NALT1 (C) genes from RNA-seq data of HeLa cells previously transfected with the indicated siRNAs. Transcript annotations are from GENCODE V44. (D–E) RT-qPCR analysis of LINC01273 (D) and NALT1 (E) ncRNA genes using total RNA harvested from HeLa cells that were previously transfected with combination of the indicated siRNAs. Data and error bars represent the means and standard deviations of five independent experiments, respectively. P-values (∗) ≤0.05; (∗∗) ≤0.01; (∗∗∗) ≤0.001; (∗∗∗∗) ≤0.0001 were determined with an unpaired Student t test.CC BY · PubMed Central
Figure 6. SNHG19 lncRNA nuclear retention is controlled by PABPN1 and ZC3H14. (A) Representative images of RNAscope in situ hybridization showing the localization of the SNHG19 lncRNA (green) in HeLa cells that were previously transfected with the indicated siRNAs. (B) Box plot showing the nuclear-to-cytoplasmic intensity ratio of SNHG19 signal for cells transfected with the indicated siRNAs. Data are from two independent experiments. In total, 91, 97, 67, and 65 cells were quantified for siControl, siPABPN1, siZC3H14, and the co-depletion of PABPN1 and ZC3H14 from two independent FISH experiments. (C) Box plot showing the nuclear-to-cytoplasmic intensity ratio of SNHG19 signal of cells lacking PABPN1 compared to cells deficient for both PABPN1 and ZC3H14. (D and E) Box plot showing the nuclear (D) and cytoplasmic (E) intensity of SNHG19 signal for cells transfected with the indicated siRNAs. ns, P value > 0.05; (∗∗), <0.01; (∗∗∗), <0.001; (∗∗∗∗),and <0.0001 were determined with an unpaired Student t test.
Figure 6. SNHG19 lncRNA nuclear retention is controlled by PABPN1 and ZC3H14. (A) Representative images of RNAscope in situ hybridization showing the localization of the SNHG19 lncRNA (green) in HeLa cells that were previously transfected with the indicated siRNAs. (B) Box plot showing the nuclear-to-cytoplasmic intensity ratio of SNHG19 signal for cells transfected with the indicated siRNAs. Data are from two independent experiments. In total, 91, 97, 67, and 65 cells were quantified for siControl, siPABPN1, siZC3H14, and the co-depletion of PABPN1 and ZC3H14 from two independent FISH experiments. (C) Box plot showing the nuclear-to-cytoplasmic intensity ratio of SNHG19 signal of cells lacking PABPN1 compared to cells deficient for both PABPN1 and ZC3H14. (D and E) Box plot showing the nuclear (D) and cytoplasmic (E) intensity of SNHG19 signal for cells transfected with the indicated siRNAs. ns, P value > 0.05; (∗∗), <0.01; (∗∗∗), <0.001; (∗∗∗∗),and <0.0001 were determined with an unpaired Student t test.CC BY · PubMed Central
Figure 7. Reducing RNA export efficiency counters the cytoplasmic accumulation of SNHG19 resulting from a PABPN1 deficiency. (A) RT-qPCR analysis of SNHG19 using total RNA prepared from HeLa cells that conditionally express (+Doxycycline) a nontarget control shRNA (shCtrl) or a PABPN1-specific shRNA (shPABPN1) and that were previously transfected with siRNAs specific to UAP56, NXF1, or a nontarget control siRNA. Data and error bars represent the means and standard deviations of six independent experiments, respectively. (B) Representative images of RNAscope in situ hybridization showing the localization of the SNHG19 lncRNA (green) in HeLa cells that conditionally express (+Doxycycline) a nontarget control shRNA (shCtrl) or a PABPN1-specific shRNA (shPABPN1) and that were previously transfected with the indicated siRNAs. (C) Box plot showing the nuclear-to-cytoplasmic intensity ratio of SNHG19 signal for cells transfected with the indicated siRNAs. In total, 59, 52, 20, and 27 cells were quantified for shCtrl cells and the siControl, siUAP56, and siNXF1 in shPABPN1-induced cells, respectively, from two independent FISH experiments. (∗∗), P-value <0.01; (∗∗∗∗), P value <0.0001 were determined with an unpaired Student t test.
Figure 7. Reducing RNA export efficiency counters the cytoplasmic accumulation of SNHG19 resulting from a PABPN1 deficiency. (A) RT-qPCR analysis of SNHG19 using total RNA prepared from HeLa cells that conditionally express (+Doxycycline) a nontarget control shRNA (shCtrl) or a PABPN1-specific shRNA (shPABPN1) and that were previously transfected with siRNAs specific to UAP56, NXF1, or a nontarget control siRNA. Data and error bars represent the means and standard deviations of six independent experiments, respectively. (B) Representative images of RNAscope in situ hybridization showing the localization of the SNHG19 lncRNA (green) in HeLa cells that conditionally express (+Doxycycline) a nontarget control shRNA (shCtrl) or a PABPN1-specific shRNA (shPABPN1) and that were previously transfected with the indicated siRNAs. (C) Box plot showing the nuclear-to-cytoplasmic intensity ratio of SNHG19 signal for cells transfected with the indicated siRNAs. In total, 59, 52, 20, and 27 cells were quantified for shCtrl cells and the siControl, siUAP56, and siNXF1 in shPABPN1-induced cells, respectively, from two independent FISH experiments. (∗∗), P-value <0.01; (∗∗∗∗), P value <0.0001 were determined with an unpaired Student t test.CC BY · PubMed Central
Figure 8. Inhibition of PAXT-dependent exosome-mediated RNA decay does not necessarily result in cytoplasmic RNA accumulation. (A) Western blot analysis of ZFC3H1 and ZC3H3 (left), RBM26 (center), and RRP40 (right) proteins using total extracts prepared from HeLa cells previously transfected with the indicated siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. The asterisk (*) indicates the position of ZC3H3. (B) Representative images of RNAscope in situ hybridization from independent experiments (Rep 1 and 2) showing the localization of the SNHG19 lncRNA (green) in HeLa cells that were previously transfected with siRNAs targeting ZFC3H1 (b, g), ZC3H3 (c, h), RBM26 and RBM27 (d, i), RRP40 (e, j), and control nontarget siRNAs (a, f). Scale bars (μm) are shown in lower left corner.
Figure 8. Inhibition of PAXT-dependent exosome-mediated RNA decay does not necessarily result in cytoplasmic RNA accumulation. (A) Western blot analysis of ZFC3H1 and ZC3H3 (left), RBM26 (center), and RRP40 (right) proteins using total extracts prepared from HeLa cells previously transfected with the indicated siRNAs. The antibodies used for Western blot analysis are shown on the right and molecular weights markers on the left. The asterisk (*) indicates the position of ZC3H3. (B) Representative images of RNAscope in situ hybridization from independent experiments (Rep 1 and 2) showing the localization of the SNHG19 lncRNA (green) in HeLa cells that were previously transfected with siRNAs targeting ZFC3H1 (b, g), ZC3H3 (c, h), RBM26 and RBM27 (d, i), RRP40 (e, j), and control nontarget siRNAs (a, f). Scale bars (μm) are shown in lower left corner.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 40 Not checked · 113 Own results and interpretations

103 more claims

Create a free account to see all 153 claims and to verify the 70 references still open.

See all claims — free account
  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 20

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 62 references

Cited by

See all 10

Metadata

Authors
Latour, M., Kwiatek, L., Landry-Voyer, A.-M., & Bachand, F.
Affiliations
Université de Sherbrooke (CA)
Corresponding author
Bachand, François
Venue
Nucleic Acids Research
Published
2025-01-24
Volume
53
Issue
3
Pages
gkaf060
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4407117690
Cited by
10
References
62
Citations by year
2026: 8 · 2025: 2
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Fonds de recherche du Québec – Santé
  • Canadian Institutes of Health Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
Keywords
PABPN1, poly(A)-binding protein, long non-coding RNA, RNA exosome, nuclear retention, cytoplasmic accumulation, nuclear RNA export
MeSH terms
Cell Nucleus, HeLa Cells, Humans, RNA, Messenger, RNA, Nuclear, RNA-Binding Proteins, RNA Stability, Polyadenylation, Poly(A)-Binding Proteins, Poly(A)-Binding Protein I, RNA, Long Noncoding, Exosome Multienzyme Ribonuclease Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance. https://app.cochat.ai/papers/10.1093/nar/gkaf060
The paper
Latour, M., Kwiatek, L., Landry-Voyer, A.-M., & Bachand, F. (2025). Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.